Market Size of Genomics Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 51.60 Billion |
Market Size (2029) | USD 103.30 Billion |
CAGR (2024 - 2029) | 14.89 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Genomics Market Analysis
The Genomics Market size is estimated at USD 51.60 billion in 2024, and is expected to reach USD 103.30 billion by 2029, growing at a CAGR of 14.89% during the forecast period (2024-2029).
COVID-19 had a significant impact on the growth of the market. The development of innovative genome technologies by various research organizations in the genomics market and a wide range of genomic products used in COVID-19 research helped researchers better understand the coronavirus. For instance, in July 2022, The Indian Institute Institute of Science (IISc) inaugurated a viral genome sequencing lab at its Center for Infectious Disease Research (CIDR). It was established to help India to Overcome the COVID-19 crisis and to prepare for future outbreaks. Researchers tried to address genetic severity and susceptibility to SARS-CoV-2 infection by using the existing genetic databases. Genome-wide association studies (GWAS) and Multi-omic-based approaches have been employed to unfold the common variants underlying host-pathogen interactions and biological networks. Additionally, the data obtained from genomes, such as ABO blood groups, and polygenic risk scores (PRS), can be potentially used to decode COVID-19 susceptibility, complications, and resistance. Moreover, biobanks that connect genomic data to electronic health records can be used to study the impact of genomic factors on the clinical course of patients infected with COVID-19. Thus, COVID-19 had a significant impact on the growth of the market during the pandemic period. Also, the demand for genomics is expected to remain intact due to the emergence of a new strain of COVID-19 in the current market scenario, thereby driving the growth of the market over the forecast period.
The major factors attributing to the growth of the genomics market are the growing government support and increased number of genomics studies, declining sequencing cost, and increased genomics applications. The genomics market is geared to exponential growth due to the essential genetic developments and their applications in numerous areas of study, such as intragenomic phenomena, like epistasis, heterosis, pleiotropy, and other associations within the genome between alleles and loci. Moreover, bioengineering and synthetic biology applications are also expected to propel the growth of the genomics market.
Governments and Research organizations in various countries are investing in research and developments in the arena of genomics for the development of new technologies. For instance, the article published in Front Line Genomics in August 2022, mentioned that the South Korean Government invested over USD 55.7 million in developing genetic testing-based treatments. This project, led by Korea University, is using genomic analysis of over 10,000 cancer patients to develop bespoke cancer treatments. Similarly, in June 2021, the Rockefeller Foundation announced over USD 20 million in funding and several non-financial collaborations to help strengthen global genomic sequencing and data sharing. Such high investments are expected to increase the usage of genomics products, which will drive overall market growth.
Additionally, the growing focus on genomics research and developments is also expected to contribute to the growth of the market. For instance, in July 2022, WHO's Science Council of experts launched for equitable expansion of genomics. The report calls for expanding access to genomic technologies, particularly in low and middle-income countries by addressing shortfalls in the financing, laboratory infrastructure, materials, and highly trained personnel. Thus these initiatives are expected to provide lucrative opportunities for the growth of the market over the forecast period.
However, factors, such as the high cost of equipment and consumables and the shortage of skilled professionals, are expected to impact market growth.
Genomics Industry Segmentation
As per the scope of the report, the genome is the organism's genetic material that contains non-coding DNA, genes, chloroplast and mitochondrial DNA. Genome analysis is known as genomics. The Genomics Market is segmented by Product and Service (Consumables, Systems and Software, and Services), Technique (PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, and Other Techniques), Application (Diagnostics, Drug Discovery and Development, Precision Medicine, and Other Applications), End User (Hospitals and Clinics, Research Centers, Pharmaceutical and Biotechnology Companies, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)The report offers the value (in USD billion) for the above-mentioned segments.
By Product and Services | |
Consumables | |
Systems and Software | |
Services |
By Techniques | |
PCR | |
Sequencing | |
Microarray | |
Nucleic Acid Extraction and Purification | |
Other Techniques |
By Application | |
Diagnostics | |
Drug Discovery and Development | |
Precision Medicine | |
Other Applications |
By End User | |
Hospitals and Clinics | |
Research Centers | |
Pharmaceutical and Biotechnology Companies | |
Other End Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Genomics Market Size Summary
The genomics market is poised for significant growth, driven by advancements in genome technologies and increased applications across various fields. The market's expansion is supported by government investments and research initiatives aimed at developing new genomic technologies and applications. The COVID-19 pandemic has notably accelerated market growth, as genomic research played a crucial role in understanding the virus and its variants. The integration of genomic data with electronic health records and biobanks has further enhanced the study of genetic factors influencing disease susceptibility and progression. Despite challenges such as high equipment costs and a shortage of skilled professionals, the market is expected to thrive due to the continuous introduction of innovative products and the declining cost of sequencing.
North America is anticipated to lead the genomics market, bolstered by substantial government funding, advanced healthcare infrastructure, and a strong presence of major industry players. The region's focus on biotechnological advancements and chronic disease management, such as cancer, contributes to its market dominance. The fragmented nature of the market sees major players like Illumina Inc., Thermo Fisher Scientific, and Agilent Technologies actively engaging in strategic partnerships and product launches to strengthen their market positions. Global initiatives to expand access to genomic technologies, particularly in low and middle-income countries, are expected to provide lucrative opportunities for market growth.
Genomics Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Applications of Genomics and Rising Government Support
-
1.2.2 Technological Advancements and Growing Adoption of Genomic Medicine
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Equipment and Consumables
-
1.3.2 Dearth of Skilled Professionals
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product and Services
-
2.1.1 Consumables
-
2.1.2 Systems and Software
-
2.1.3 Services
-
-
2.2 By Techniques
-
2.2.1 PCR
-
2.2.2 Sequencing
-
2.2.3 Microarray
-
2.2.4 Nucleic Acid Extraction and Purification
-
2.2.5 Other Techniques
-
-
2.3 By Application
-
2.3.1 Diagnostics
-
2.3.2 Drug Discovery and Development
-
2.3.3 Precision Medicine
-
2.3.4 Other Applications
-
-
2.4 By End User
-
2.4.1 Hospitals and Clinics
-
2.4.2 Research Centers
-
2.4.3 Pharmaceutical and Biotechnology Companies
-
2.4.4 Other End Users
-
-
2.5 Geography
-
2.5.1 North America
-
2.5.1.1 United States
-
2.5.1.2 Canada
-
2.5.1.3 Mexico
-
-
2.5.2 Europe
-
2.5.2.1 Germany
-
2.5.2.2 United Kingdom
-
2.5.2.3 France
-
2.5.2.4 Italy
-
2.5.2.5 Spain
-
2.5.2.6 Rest of Europe
-
-
2.5.3 Asia-Pacific
-
2.5.3.1 China
-
2.5.3.2 Japan
-
2.5.3.3 India
-
2.5.3.4 Australia
-
2.5.3.5 South Korea
-
2.5.3.6 Rest of Asia-Pacific
-
-
2.5.4 Middle East and Africa
-
2.5.4.1 GCC
-
2.5.4.2 South Africa
-
2.5.4.3 Rest of Middle East and Africa
-
-
2.5.5 South America
-
2.5.5.1 Brazil
-
2.5.5.2 Argentina
-
2.5.5.3 Rest of South America
-
-
-
Genomics Market Size FAQs
How big is the Genomics Market?
The Genomics Market size is expected to reach USD 51.60 billion in 2024 and grow at a CAGR of 14.89% to reach USD 103.30 billion by 2029.
What is the current Genomics Market size?
In 2024, the Genomics Market size is expected to reach USD 51.60 billion.